Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Update on the Use of Phosphodiesterase Inhibitors in the Treatment of Erectile Dysfunction

Update on the Use of Phosphodiesterase Inhibitors in the Treatment of Erectile Dysfunction Oral therapy for erectile dysfunction with type-5 phosphodiesterase (PDE5) inhibitors has revolutionized treatment. This review presents a comprehensive update on PDE5 inhibitors and covers areas including erectile physiology, pharmacology, dosing and side effects. In addition, the use of these drugs in certain clinical situations including cardiovascular disease, as well as a discussion of rare adverse events, daily dosing, use of these drugs for the treatment of lower urinary tract systems, recreational use, novel uses for PDE5 inhibitors, and strategies for treatment failures are covered in detail. Because of the widespread use of PDE5 inhibitors for the treatment of erectile dysfunction, a comprehensive under-standing of these issues by health-care providers is necessary to ensure safe and effective prescribing practices and to improve patient satisfaction and quality of life. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Urology Karger

Update on the Use of Phosphodiesterase Inhibitors in the Treatment of Erectile Dysfunction

Loading next page...
 
/lp/karger/update-on-the-use-of-phosphodiesterase-inhibitors-in-the-treatment-of-v9A2By0gMj
Publisher
Karger
Copyright
© 2008 S. Karger AG, Basel
ISSN
1661-7649
eISSN
1661-7657
DOI
10.1159/000189651
Publisher site
See Article on Publisher Site

Abstract

Oral therapy for erectile dysfunction with type-5 phosphodiesterase (PDE5) inhibitors has revolutionized treatment. This review presents a comprehensive update on PDE5 inhibitors and covers areas including erectile physiology, pharmacology, dosing and side effects. In addition, the use of these drugs in certain clinical situations including cardiovascular disease, as well as a discussion of rare adverse events, daily dosing, use of these drugs for the treatment of lower urinary tract systems, recreational use, novel uses for PDE5 inhibitors, and strategies for treatment failures are covered in detail. Because of the widespread use of PDE5 inhibitors for the treatment of erectile dysfunction, a comprehensive under-standing of these issues by health-care providers is necessary to ensure safe and effective prescribing practices and to improve patient satisfaction and quality of life.

Journal

Current UrologyKarger

Published: Jan 1, 2009

Keywords: Erectile dysfunction; Phosphodiesterase inhibitors

There are no references for this article.